J&J

J&J Seeks Approval For Clinical Trials Of Its Single-Shot COVID-19 Vaccine On Adolescents Aged 12-17 Years In India
J&J Seeks Approval For Clinical Trials Of Its Single-Shot COVID-19 Vaccine On Adolescents Aged 12-17 Years In IndiaSwarajya StaffAug 20, 2021 07:36 AM
J&J's Single-Shot COVID-19 Vaccine Becomes Fifth Jab To Get Approval For Emergency Use In India
J&J's Single-Shot COVID-19 Vaccine Becomes Fifth Jab To Get Approval For Emergency Use In IndiaSwarajya StaffAug 7, 2021 08:18 AM
US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In India
US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In IndiaSwarajya StaffAug 6, 2021 10:44 AM
AHPI Close To Striking A Deal For Import Of J&J's Single-Dose COVID-19 Vaccine Into India Early Next Month
AHPI Close To Striking A Deal For Import Of J&J's Single-Dose COVID-19 Vaccine Into India Early Next MonthSwarajya StaffJun 26, 2021 08:23 AM
Bullish Scenario For Vaccine Rollout: How India Might Achieve Herd Immunity By Dussehra
Bullish Scenario For Vaccine Rollout: How India Might Achieve Herd Immunity By DussehraSwarajya StaffApr 20, 2021 01:10 PM
Covid-19 Vaccine Could Be Ready By October End, Claims Pharma Major Pfizer’s CEO
Covid-19 Vaccine Could Be Ready By October End, Claims Pharma Major Pfizer’s CEOIANSMay 30, 2020 07:36 AM
Double Trouble For Johnson & Johnson: After Asbestos Panic, Now It’s Faulty Hip Transplants
Double Trouble For Johnson & Johnson: After Asbestos Panic, Now It’s Faulty Hip TransplantsSwarajya StaffMar 11, 2019 05:07 AM
Load More